Holen Sie sich die Stockscreener-App
0.805
0.25%
0.002
Vorhandelsmarkt:
.81
0.005
+0.62%
Schlusskurs vom Vortag:
$0.803
Offen:
$0.7944
24-Stunden-Volumen:
646.61K
Relative Volume:
0.31
Marktkapitalisierung:
$5.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.60M
KGV:
-0.9045
EPS:
-0.89
Netto-Cashflow:
$-23.48M
1W Leistung:
+4.27%
1M Leistung:
-73.69%
6M Leistung:
-86.78%
1J Leistung:
-92.22%
1-Tages-Spanne:
$0.7802
$0.81
1-Wochen-Bereich:
$0.7802
$0.8422
52-Wochen-Spanne:
$0.69
$29.40
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Firmenname
Briacell Therapeutics Corp
Sektor
Branche
Telefon
(604) 921-1810
Adresse
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Vergleichen Sie BCTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
0.805 | 5.23M | 0 | -16.60M | -23.48M | -0.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-02-14 | Eingeleitet | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten
BriaCell Therapeutics Corp. Equity Warrant Stock Analysis and ForecastRapid market gains - jammulinksnews.com
What analysts say about BriaCell Therapeutics Corp. stockFree Bull & Bear Market Updates - jammulinksnews.com
What drives BriaCell Therapeutics Corp. Equity Warrant stock priceExplosive portfolio gains - jammulinksnews.com
Is BriaCell Therapeutics Corp. Equity Warrant a good long term investmentFree Investment Case Studies - jammulinksnews.com
BriaCell Therapeutics Corp. Stock Analysis and ForecastRapid-fire capital growth - jammulinksnews.com
What analysts say about BriaCell Therapeutics Corp. Equity Warrant stockSky-high return potential - Autocar Professional
What drives BriaCell Therapeutics Corp. stock priceExceptional trading results - jammulinksnews.com
Is BriaCell Therapeutics Corp. a good long term investmentExceptional ROI - jammulinksnews.com
ProShares Trust ProShares Ultra Consumer Discretionary Stock Analysis and ForecastOverwhelming financial success - Autocar Professional
Filatex India Limited (FILATEX) to Launch New Product LineFast-track wealth growth - Autocar Professional
Best Dividend Growth Stocks in India Short Term Trade OpportunitiesOutstanding capital appreciation - jammulinksnews.com
DOMS Industries Limited (DOMS) Quarterly Results Are OutGame-changing returns - jammulinksnews.com
QTTB Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Kunststoffe Industries Limited (523594) to Launch New Product LineTremendous portfolio expansion - jammulinksnews.com
Best Stocks’s Technology Sector Short Term Investment PicksRobust investment performance - jammulinksnews.com
What makes BriaCell Therapeutics Corp. stock price move sharplyTop Gaining Low Risk Assets - beatles.ru
CMPR Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
(BCT) Investment Analysis (BCT:CA) - news.stocktradersdaily.com
BriaCell Shares Slide 22% After Announcing Dilutive Public Offering - MSN
BriaCell Therapeutics Announces Closing of $15 million Public Offering - GlobeNewswire
BriaCell Therapeutics Secures $15 Million in Public Offering - TipRanks
BriaCell Secures $15M Funding Boost for Cancer Immunotherapy Development at $1.25 Per Unit - Stock Titan
BCTX files $15M unit offering; share count could triple post-deal | CMCL SEC FilingForm 6-K - Stock Titan
BriaCell Prices $15 Mln Public Offering To Fund Operations And Growth Initiatives - Nasdaq
BriaCell Therapeutics (BCTX) Plunges 61.78% After $15M Public Offering - AInvest
BriaCell (BCTX) Announces $15M Public Offering of Common Shares and Warrants | BCTX Stock News - GuruFocus
BriaCell Therapeutics Announces Pricing of $15 million Public Offering | BCTX Stock News - GuruFocus
BriaCell says $15M unit offering prices at $1.25 per unit - TipRanks
Briacell Therapeutics announces pricing of $15 million public offering - MarketScreener
BriaCell Therapeutics Announces Pricing of $15 million Public Offering - GlobeNewswire
Cancer Immunotherapy Developer BriaCell Secures $15M Funding: What the Deal Means for Investors - Stock Titan
BCTX Stock Surges Amid Positive Developments and Strategic Moves - StocksToTrade
(BCT) Proactive Strategies (BCT:CA) - news.stocktradersdaily.com
Finanzdaten der Briacell Therapeutics Corp-Aktie (BCTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):